Inventor · disambiguated record
Sharon Shacham
Also filed as: SHACHAM SHARON
50 granted patents·20 pending applications·681 citations·filing 2004–2023
99Inventor score
Files withKARYOPHARM THERAPEUTICS INC33EPIX DELAWARE INC11BIOGEN MA INC6EPIX PHARM INC4DHANOA DALE S3
Top patents by PatentIndex Score
70 records- 0198US11787771B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2021·Granted Oct 17, 2023·5 cites·12 claims
- 0297US12291508B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2023·Granted May 6, 2025·2 cites·15 claims
- 0397US11034660B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2019·Granted Jun 15, 2021·10 cites·13 claims
- 0497US10335393B2Nuclear transport modulators and uses thereofBIOGEN MA INC·Filed 2017·Granted Jul 2, 2019·20 cites·12 claims
- 0597US10173987B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2017·Granted Jan 8, 2019·18 cites·12 claims
- 0697US10058535B2Nuclear transport modulators and uses thereofBIOGEN MA INC·Filed 2017·Granted Aug 28, 2018·24 cites·1 claims
- 0797US9861614B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2015·Granted Jan 9, 2018·27 cites·19 claims
- 0897US9714226B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2015·Granted Jul 25, 2017·28 cites·8 claims
- 0997US9585874B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2016·Granted Mar 7, 2017·27 cites·19 claims
- 1097US9266843B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2013·Granted Feb 23, 2016·31 cites·6 claims
- 1197US9206158B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2015·Granted Dec 8, 2015·28 cites·2 claims
- 1297US9096543B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2013·Granted Aug 4, 2015·35 cites·35 claims
- 1397US8999996B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2014·Granted Apr 7, 2015·44 cites·2 claims
- 1496US10544108B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2018·Granted Jan 28, 2020·14 cites·7 claims
- 1596US9079865B2Hydrazide containing nuclear transport modulators and uses thereofSANDANAYAKA VINCENT P·Filed 2012·Granted Jul 14, 2015·38 cites·13 claims
- 1695US11945794B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2021·Granted Apr 2, 2024·4 cites·18 claims
- 1795US11124493B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2019·Granted Sep 21, 2021·12 cites·10 claims
- 1894US10722497B2Nuclear transport modulators and uses thereofBIOGEN MA INC·Filed 2019·Granted Jul 28, 2020·3 cites·26 claims
- 1994US10407405B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2017·Granted Sep 10, 2019·21 cites·19 claims
- 2093US9738624B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2014·Granted Aug 22, 2017·29 cites·19 claims
- 2193US9550757B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2013·Granted Jan 24, 2017·24 cites·25 claims
- 2292US10617677B2Nuclear transport modulators and uses thereofBIOGEN MA INC·Filed 2018·Granted Apr 14, 2020·3 cites·18 claims
- 2392US10202366B2Methods of promoting wound healing using CRM1 inhibitorsKARYOPHARM THERAPEUTICS INC·Filed 2014·Granted Feb 12, 2019·22 cites·6 claims
- 2492US9428490B2Nuclear transport modulators and uses thereofSANDANAYAKA VINCENT P·Filed 2012·Granted Aug 30, 2016·27 cites·8 claims
- 2592US9303000B2Olefin containing nuclear transport modulators and uses thereofSANDANAYAKA VINCENT P·Filed 2012·Granted Apr 5, 2016·28 cites·10 claims
- 2692US8513230B2Nuclear transport modulators and uses thereofSHACHAM SHARON·Filed 2011·Granted Aug 20, 2013·39 cites·7 claims
- 2788US10399963B2Substituted benzofuranyl and benzoxazolyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2017·Granted Sep 3, 2019·5 cites·17 claims
- 2888US7919519B2S1P receptor modulating compounds and use thereofEPIX PHARM INC·Filed 2007·Granted Apr 5, 2011·14 cites·8 claims
- 2987US9994558B2Multicyclic compounds and methods of using sameKARYOPHARM THERAPEUTICS INC·Filed 2014·Granted Jun 12, 2018·6 cites·17 claims
- 3087US9856241B2Substituted benzofuranyl and benzoxazolyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2014·Granted Jan 2, 2018·8 cites·16 claims
- 3186US11008309B2Substituted benzofuranyl and benzoxazolyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2019·Granted May 18, 2021·2 cites·20 claims
- 3286US7968538B2Substituted arylamine compounds and methods of treatmentGALENEA CORP·Filed 2006·Granted Jun 28, 2011·17 cites·60 claims
- 3385US10925859B2Nuclear transport modulators and uses thereofBIOGEN MA INC·Filed 2020·Granted Feb 23, 2021·1 cites·21 claims
- 3485US10363247B2(S,E)-3-(6-aminopyridin-3-yl)-N-((5-(4-(3-fluoro-3-methylpyrrolidine-1-carbonyl)phenyl-7-(4-fluorophenyl)benzofuran-2-yl)methyl)acrylamide for the treatment of cancerKARYOPHARM THERAPEUTICS INC·Filed 2016·Granted Jul 30, 2019·5 cites·15 claims
- 3584US7576211B2Synthesis of thienopyridinone compounds and related intermediatesEPIX DELAWARE INC·Filed 2005·Granted Aug 18, 2009·5 cites·2 claims
- 3683US7598265B2Compositions and methods for treating CNS disordersEPIX DELAWARE INC·Filed 2005·Granted Oct 6, 2009·7 cites·25 claims
- 3783US2024376114A1Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3882US9938258B2Substituted 2,3-dihydrobenzofuranyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2013·Granted Apr 10, 2018·6 cites·12 claims
- 3982US7982040B2Thienopyridinone compounds and methods of treatmentNANOTHERAPEUTICS INC·Filed 2008·Granted Jul 19, 2011·5 cites·16 claims
- 4079US7488731B2Arylpiperazinyl compoundsEPIX DELAWARE INC·Filed 2007·Granted Feb 10, 2009·3 cites·9 claims
- 4179US7488736B2Thienopyridinone compounds and methods of treatmentEPIX DELAWARE INC·Filed 2004·Granted Feb 10, 2009·11 cites·16 claims
- 4278US11318120B2Nuclear transport modulators and uses thereofBIOGEN MA INC·Filed 2021·Granted May 3, 2022·0 cites·6 claims
- 4378US7407966B2Thienopyridinone compounds and methods of treatmentEPIX DELAWARE INC·Filed 2004·Granted Aug 5, 2008·12 cites·13 claims
- 4477US7855193B2S1P receptor modulating compounds and use thereofEPIX PHARM INC·Filed 2006·Granted Dec 21, 2010·3 cites·11 claims
- 4574US12331040B2Substituted benzofuranyl and benzoxazolyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2021·Granted Jun 17, 2025·0 cites·31 claims
- 4674US7612078B2Piperidinylamino-thieno[2,3-D] pyrimidine compoundsEPIX DELAWARE INC·Filed 2005·Granted Nov 3, 2009·2 cites·16 claims
- 4772US8569259B2Adenosine analogs and their useBEN-ZEEV EFRAT·Filed 2007·Granted Oct 29, 2013·2 cites·21 claims
- 4872US7491727B2Arylpiperazinyl compoundsEPIX DELAWARE INC·Filed 2006·Granted Feb 17, 2009·1 cites·8 claims
- 4972US2022056038A1Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 5071US8604021B2Substituted arylamine compounds and methods of treatmentBECKER OREN·Filed 2011·Granted Dec 10, 2013·3 cites·15 claims
Showing the top 50 of 70 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Sharon Shacham files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →